Pay in 4 interest-free payments of $5.51 Learn more
Ships within 48 hours · Estimated delivery Aug 8 - Aug 13
Anlisis estadstico Para evaluar la normalidad se aplic la prueba de Shapiro Wilk y para la homogeneidad de varianzas se us la prueba de Bartlett
Long-term bariatric surgery outcomes are consistently durable, with major societies noting sustained weight loss years after surgery
For female athletes, already disproportionately vulnerable to these conditions, the risks are particularly acute
At TrimRx, we understand that managing your health requires both clinical precision and real-world flexibility
TRIUMPH-1 (NCT05929066), the Phase 3 registration trial for the obesity indication, reported topline results on May 21, 2026 : average weight loss of 28.3% at 80 weeks at the highest dose in 2,339 participants, versus 2.2% on placebo, and 30.3% at 104 weeks among participants with a BMI of 35 or above who continued in a pre-specified extension
US$ 24.32
US$ 28.97
US$ 28.77
US$ 21.93
US$ 21.68
US$ 22.44
US$ 20.21
US$ 28.94
